ouabain has been researched along with atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahluwalia, A; Foster, P; Hobbs, A; Prescott, C; Scotland, R | 1 |
1 other study(ies) available for ouabain and atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-
| Article | Year |
|---|---|
Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
Topics: Acetylcholine; Animals; Atrial Natriuretic Factor; Barium; Coronary Circulation; Drug Evaluation, Preclinical; Endothelium, Vascular; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ouabain; Peptide Fragments; Rats; Rats, Wistar; Receptors, Atrial Natriuretic Factor; Signal Transduction; Vasodilation; Vasodilator Agents | 2004 |